Cytokinetics, Incorporated · NASDAQ:CYTK

Blum Robert I sold 7,500 Cytokinetics, Incorporated shares (Form 4)

Traded Nov 2, 2026 · Filed Nov 2, 2026

On Nov 2, 2026, Blum Robert I (Director, President & CEO) sold 7,500 Cytokinetics, Incorporated shares at US$62.81 for US$471K under a trading plan, leaving 278,544 shares. Filed Nov 2, 2026 (Form 4).

Sold
7,500 shares
Price
US$62.81
Value
US$471K
Holding after
278,544 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, President & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Nov 2, 2026Common StockOption exercise7,500US$10.60286,044Direct
Nov 2, 2026Common StockSale7,500US$62.81278,544Direct

Source

Download original · View original at SEC

Related